15-45116216-C-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_207581.4(DUOXA2):c.298C>G(p.Arg100Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.977 in 1,613,990 control chromosomes in the GnomAD database, including 777,520 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.87 ( 61048 hom., cov: 32)
Exomes 𝑓: 0.99 ( 716472 hom. )
Consequence
DUOXA2
NM_207581.4 missense
NM_207581.4 missense
Scores
1
17
Clinical Significance
Conservation
PhyloP100: 7.48
Genes affected
DUOXA2 (HGNC:32698): (dual oxidase maturation factor 2) This gene encodes an endoplasmic reticulum protein that is necessary for proper cellular localization and maturation of functional dual oxidase 2. Mutations in this gene have been associated with thyroid dyshormonogenesis 5.[provided by RefSeq, Feb 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
?
Computational evidence support a benign effect (MetaRNN=1.2533039E-6).
BP6
?
Variant 15-45116216-C-G is Benign according to our data. Variant chr15-45116216-C-G is described in ClinVar as [Benign]. Clinvar id is 263302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-45116216-C-G is described in Lovd as [Benign].
BA1
?
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DUOXA2 | NM_207581.4 | c.298C>G | p.Arg100Gly | missense_variant | 3/6 | ENST00000323030.6 | |
DUOXA2 | XM_017022180.2 | c.298C>G | p.Arg100Gly | missense_variant | 3/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DUOXA2 | ENST00000323030.6 | c.298C>G | p.Arg100Gly | missense_variant | 3/6 | 1 | NM_207581.4 | P1 | |
DUOXA2 | ENST00000491993.2 | c.*365C>G | 3_prime_UTR_variant, NMD_transcript_variant | 3/6 | 1 | ||||
DUOXA2 | ENST00000350243.10 | n.578C>G | non_coding_transcript_exon_variant | 3/5 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.874 AC: 132879AN: 152034Hom.: 61037 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
132879
AN:
152034
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.969 AC: 241874AN: 249510Hom.: 118692 AF XY: 0.977 AC XY: 132260AN XY: 135382
GnomAD3 exomes
AF:
AC:
241874
AN:
249510
Hom.:
AF XY:
AC XY:
132260
AN XY:
135382
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.988 AC: 1443770AN: 1461838Hom.: 716472 Cov.: 73 AF XY: 0.989 AC XY: 719544AN XY: 727210
GnomAD4 exome
AF:
AC:
1443770
AN:
1461838
Hom.:
Cov.:
73
AF XY:
AC XY:
719544
AN XY:
727210
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.874 AC: 132937AN: 152152Hom.: 61048 Cov.: 32 AF XY: 0.880 AC XY: 65467AN XY: 74390
GnomAD4 genome
?
AF:
AC:
132937
AN:
152152
Hom.:
Cov.:
32
AF XY:
AC XY:
65467
AN XY:
74390
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
3706
ALSPAC
AF:
AC:
3854
ESP6500AA
AF:
AC:
2331
ESP6500EA
AF:
AC:
8287
ExAC
?
AF:
AC:
116215
Asia WGS
AF:
AC:
3396
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Thyroglobulin synthesis defect Benign:2
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 05, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
P
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at